Crossmark

A prospective feasibility study of uracil–tegafur and leucovorin as adjuvant chemotherapy for patients aged ≥ 80 years after curative resection of colorectal cancer, the HiSCO-03 study

Crossref DOI link: https://doi.org/10.1007/s00280-023-04526-7

Published Online: 2023-03-22

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Okuda, Hiroshi

Shimomura, Manabu

Ikeda, Satoshi https://orcid.org/0000-0002-6285-6643
Nakahara, Masahiro

Miguchi, Masashi

Ishizaki, Yasuyo

Saitoh, Yasuhumi

Toyota, Kazuhiro

Sumitani, Daisuke

Shimizu, Yosuke

Takakura, Yuji

Shimizu, Wataru

Yoshimitsu, Masanori

Kodama, Shinya

Fujimori, Masahiko

Oheda, Mamoru

Kobayashi, Hironori

Ohdan, Hideki

,
License Information

Text and Data Mining valid from 2023-03-22

Version of Record valid from 2023-03-22
More Information

Article History

Received: 12 December 2022

Accepted: 16 March 2023

First Online: 22 March 2023

Declarations

:

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below